Who owns ACURX PHARMACEUTICALS INC COM NEW?

Tip: Access positions for across all investors

Analyze quarterly positions in Acurx Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Acurx Pharmaceuticals stock

Who bought or sold ACURX PHARMACEUTICALS INC COM NEW this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Jane Street 55k $203k 409% Mar 2026
 View chart
Vanguard Capital Management 31k $115k 100% Mar 2026
 View chart
Geode Capital Management 25k $92k 100% Mar 2026
 View chart
Vanguard Group 23k $58k 100% Dec 2025
 View chart
Cambridge Investment Research Advisors 20k $74k 100% Mar 2026
 View chart
Northern Trust 17k $42k 100% Dec 2025
 View chart
Vanguard Fiduciary Trust 16k $60k 100% Mar 2026
 View chart
Prospect Financial Services 14k $51k -30% Mar 2026
 View chart
Morgan Stanley 6.5k $24k 0% Mar 2026
 View chart
UBS Group 6.3k $24k 3635% Mar 2026
 View chart
Tower Research Capital 2.9k $7.2k 168% Dec 2025
 View chart
Wells Fargo & Company 2.3k $8.5k 0% Mar 2026
 View chart
Westside Investment Management 1.7k $6.1k 100% Mar 2026
 View chart
Nbc Securities 1.5k $5.6k 0% Mar 2026
 View chart
Western Wealth Management 1.3k $4.9k 100% Mar 2026
 View chart
Group One Trading 245.00 $908.999000 -13% Mar 2026
 View chart
Cornerstone Planning Group 167.00 $334.000000 0% Mar 2026
 View chart
Advisor Group Holdings 100.00 $249.000000 -59% Dec 2025
 View chart
BlackRock 60.00 $223.002000 0% Mar 2026
 View chart
SBI Securities 6.00 $22.000200 -54% Mar 2026
 View chart
Citigroup 1.00 $4.000000 100% Mar 2026
 View chart

Who sold out of Acurx Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Millennium Management Dec 2025 41k $103k
Susquehanna International Sep 2025 17k $72k
Sabby Management Sep 2025 8.7k $37k
GPS Wealth Strategies Group Sep 2025 1.2k $5.3k
Advisory Services Network Sep 2025 59.00 $252.997900